Who has invested in Imcyse?

Biogenosis, Epimede, KU Leuven, LSP, Noshaq, Pfizer are named among the investors backing Imcyse.

Imcyse Funding: $65M Raised, Series B (2021)

Imcyse funding overview

Imcyse is based in Liège, Belgium. Imcyse has raised $65M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in February 2021. The round record for Imcyse runs through 2021; nothing later has been disclosed. Investors on record include Biogenosis, Epimede, KU Leuven, LSP, Noshaq, Pfizer and 4 others. 10 distinct backers are named across the disclosed rounds.

Imcyse at a glance

Total raised: $65M
Latest round: Series B
Latest round date: February 2021
Headquarters: Liège, Belgium
Notable investors: Biogenosis, Epimede, KU Leuven, LSP, Noshaq, Pfizer, Sfpi Fpim, Sriw

Frequently asked about Imcyse funding

How much has Imcyse raised?: Imcyse has raised $65M in total disclosed funding across the rounds on record.
Who has invested in Imcyse?: Biogenosis, Epimede, KU Leuven, LSP, Noshaq, Pfizer are named among the investors backing Imcyse.
What was the latest Imcyse funding round?: The most recent disclosed round is a Series B, announced in February 2021.
Where is Imcyse based?: Imcyse is based in Liège, Belgium.
When did Imcyse last raise?: The last disclosed Imcyse round closed in February 2021 at Series B.

Imcyse totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Liège below to benchmark round size and investor mix.

Imcyse Funding: $65M Raised, Series B (2021)

Imcyse funding overview

Imcyse at a glance

Frequently asked about Imcyse funding

Companies related to Imcyse (32)

Browse related funding lists (5)